Allvivo Vascular

Allvivo Vascular

Medical Devices, Walnut Rd, Castro Valley, , 94546, California, 18725, United States, 1-10 Employees

allvivo.com

  • facebook
  • LinkedIn

phone no Phone Number: 94********

Who is ALLVIVO VASCULAR

Allvivo Vascular develops biomimetic coatings for medical devices. AVIs lead products are GatekeeperTM and ProteoGuard. Gatekeeper is a dual function coating that combines the benefits of...

Read More

map
  • 18725 Walnut Rd, Castro Valley, California, 94546, United States Headquarters: 18725 Walnut Rd, Castro Valley, California, 94546, United States
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $5 Million to $10 Million

industries-icon Industry: Medical Devices

SIC SIC Code: 6531 | NAICS Code: 541715 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ALLVIVO VASCULAR

Allvivo Vascular Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Allvivo Vascular

Answer: Allvivo Vascular's headquarters are located at Walnut Rd, Castro Valley, , 94546, California, 18725, United States

Answer: Allvivo Vascular's phone number is 94********

Answer: Allvivo Vascular's official website is https://allvivo.com

Answer: Allvivo Vascular's revenue is $5 Million to $10 Million

Answer: Allvivo Vascular's SIC: 6531

Answer: Allvivo Vascular's NAICS: 541715

Answer: Allvivo Vascular has 1-10 employees

Answer: Allvivo Vascular is in Medical Devices

Answer: Allvivo Vascular contact info: Phone number: 94******** Website: https://allvivo.com

Answer: Allvivo Vascular develops biomimetic coatings for medical devices. AVIs lead products are GatekeeperTM and ProteoGuard. Gatekeeper is a dual function coating that combines the benefits of a nonthrombogenic surface with an active antibacterial agent. ProteoGuard actively downregulates inflammatory responses to devices and is highly thromboresistant. The ProteoGuard stent coating provides a promising alternative to the use of immune-suppressive and cytotoxic drugs to prevent restenosis, while eliminating the requirement for long term dual antiplatelet therapy.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access